Grufity logoGrufity logo
StocksFundsSearch Filings

NU Skin Enterprises Inc Stock Research

NUS

34.55USD-0.05(-0.14%)Market Closed

Market Summary

USD34.55-0.05
Market Closed
-0.14%

NUS Alerts

NUS Stock Price

NUS RSI Chart

NUS Valuation

Market Cap

2.0B

Price/Earnings (Trailing)

19.48

Price/Sales (Trailing)

0.92

EV/EBITDA

11

Price/Free Cashflow

41.64

NUS Price/Sales (Trailing)

NUS Profitability

EBT Margin

4.00%

Return on Equity

11.68%

Return on Assets

5.75%

Free Cashflow Yield

2.4%

NUS Fundamentals

NUS Revenue

Revenue (TTM)

2.1B

Revenue Y/Y

-20.41%

Revenue Q/Q

-7.83%

NUS Earnings

Earnings (TTM)

77.4M

Earnings Y/Y

-70.62%

Earnings Q/Q

-80.12%

Price Action

52 Week Range

29.9647.84
(Low)(High)

Last 7 days

-4.7%

Last 30 days

-12.6%

Last 90 days

-15.5%

Trailing 12 Months

-23.9%

NUS Financial Health

Current Ratio

2.12

Debt/Equity

0.4

Debt/Cashflow

0.51

NUS Investor Care

Shares Dilution (1Y)

0.20%

Diluted EPS (TTM)

1.52

Peers (Alternatives to NU Skin Enterprises)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
357.9B
81.0B
-5.94% 0.62%
25.07
4.46
1.70% -1.88%
69.6B
15.9B
-19.27% -18.92%
46.06
4.38
-12.42% -53.65%
63.2B
18.3B
-0.61% -1.25%
35.42
3.52
4.93% -21.82%
48.5B
20.3B
-5.09% 3.86%
24.55
2.39
2.95% 12.78%
19.7B
7.2B
-2.66% 10.48%
265.75
2.74
0.89% -83.84%
MID-CAP
9.4B
5.4B
-5.40% 65.12%
48.53
1.75
3.31% -45.41%
5.0B
1.5B
4.63% 42.35%
33.6
3.32
14.86% 415.33%
2.1B
2.2B
-5.61% 12.71%
22.11
0.94
4.71% -20.28%
SMALL-CAP
2.0B
2.1B
-12.60% -23.87%
19.48
0.92
-19.87% -44.11%
1.2B
5.1B
-18.14% -45.86%
4.66
0.23
-9.16% -36.58%
893.8M
1.6B
-9.97% -50.57%
6.31
0.56
4.75% -13.96%
209.5M
420.1M
4.46% -10.50%
380.9
0.5
-7.10% -98.18%
85.9M
21.3M
-18.75% -91.77%
-0.62
4.03
-64.80% -404.09%
64.2M
49.4M
-8.16% -11.41%
179.82
1.22
-14.86% -18.38%
58.2M
210.1M
37.35% 12.32%
-69.16
0.28
-0.04% -108.92%

Financials for NU Skin Enterprises

Income Statement (Last 12 Months)
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q12022Q42022Q32022Q22022Q1
Revenue-5.5%2,1022,2262,3772,4802,624
Gross Profit-6.0%1,4991,5951,7201,8381,957
Operating Expenses-4.0%1,4241,4841,6161,6481,734
  S&GA Expenses-6.2%8258809429861,047
EBITDA3.9%161155254294-
EBITDA Margin10.9%0.07*0.07*5.02*0.11*-
Earnings Before Taxes-40.6%53.0089.0083.00180219
EBT Margin14.4%0.04*0.03*3.56*0.08*-
Net Income-26.1%77.0010538.00113139
Net Income Margin191.9%0.05*0.02*2.24*0.05*-
Free Cahsflow-61.9%49.00129142108-
Balance Sheet
(In Millions)
Description(%) Q/Q2023Q12022Q42022Q32022Q22022Q1
Assets0.2%1,8251,8211,7631,9011,892
  Current Assets1.8%774760778883849
    Cash Equivalents-13.1%230265294364302
  Inventory5.9%367346327354382
  Net PPE-1.5%438445433443449
  Goodwill0%206206206206206
Liabilities0.9%932924921960958
  Current Liabilities3.8%373359366384494
    LT Debt, Current90.0%48.0025.0043.0040.00110
    LT Debt, Non Current-1.3%373377382387259
Shareholder's Equity-0.5%893897842941934
  Retained Earnings-0.4%1,9311,9391,9011,9461,931
  Additional Paid-In Capital-0.3%611613610606599
Shares Outstanding-0.3%50.0050.0050.00--
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2023Q12022Q42022Q32022Q22022Q1
Cashflow From Operations-27.4%78.00108192194168
  Share Based Compensation-1.0%12.0012.0016.0016.0021.00
Cashflow From Investing-6.8%-71.64-67.08-69.27-61.97-80.06
Cashflow From Financing35.3%-64.36-99.50-84.63-103-120
  Dividend Payments0.1%77.0077.0077.0077.0076.00
  Buy Backs-14.3%60.0070.0070.0040.0040.00

Risks for NUS

What is the probability of a big loss on NUS?

81.9%


Probability that NU Skin Enterprises stock will be more than 20% underwater in next one year

70.8%


Probability that NU Skin Enterprises stock will be more than 30% underwater in next one year.

38.1%


Probability that NU Skin Enterprises stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does NUS drawdown profile look like?

Y-axis is the maximum loss one would have experienced if NU Skin Enterprises was unfortunately bought at previous high price.

Drawdowns

Returns for NUS

Cumulative Returns on NUS

-3.0%


10-Year Cumulative Returns

0.5%


7-Year Cumulative Returns

-13.4%


5-Year Cumulative Returns

0.1%


3-Year Cumulative Returns

What are the long-term rolling returns for NUS?

FIve years rolling returns for NU Skin Enterprises.

Annualized Returns

Which funds bought or sold NUS recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-05-23
ROYCE & ASSOCIATES LP
new
-
768,864
768,864
0.01%
2023-05-22
EMC Capital Management
unchanged
-
-14,000
190,000
0.16%
2023-05-22
AMERIPRISE FINANCIAL INC
reduced
-1.35
-747,441
8,566,560
-%
2023-05-18
JPMORGAN CHASE & CO
reduced
-20.2
-2,355,450
6,853,550
-%
2023-05-18
NEW YORK STATE COMMON RETIREMENT FUND
reduced
-27.93
-496,000
1,015,000
-%
2023-05-17
Thrivent Financial for Lutherans
reduced
-3.39
-212,000
1,925,000
-%
2023-05-17
VIRGINIA RETIREMENT SYSTEMS ET AL
reduced
-9.33
130,172
1,024,490
0.01%
2023-05-17
Advisory Services Network, LLC
sold off
-
-
-
-%
2023-05-16
JANE STREET GROUP, LLC
added
75.37
704,074
1,812,540
-%
2023-05-16
Baker Avenue Asset Management, LP
sold off
-100
-211
-
-%

1–10 of 42

Latest Funds Activity

Are funds buying NUS calls or puts?
Calls
Puts
Are funds bullish or bearish(Calls - Puts)?
Net Call Options
No. of funds that own NUS
No. of Funds

NU Skin Enterprises News

MarketBeat
Insider Selling: Nu Skin Enterprises, Inc. (NYSE:NUS) Director Sells ....
MarketBeat,
4 hours ago
Simply Wall St
InvestorsObserver
Beaumont Enterprise
Nu Skin: Q1 Earnings Snapshot.
Beaumont Enterprise,
25 days ago
PR Newswire

Schedule 13G FIlings of NU Skin Enterprises

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2023
renaissance technologies llc
4.63%
2,287,596
SC 13G/A
Feb 09, 2023
vanguard group inc
13.13%
6,490,840
SC 13G/A
Feb 09, 2023
state street corp
14.94%
7,384,649
SC 13G/A
Feb 06, 2023
wellington management group llp
7.15%
3,535,969
SC 13G/A
Jan 23, 2023
blackrock inc.
17.0%
8,414,765
SC 13G/A
May 10, 2022
state street corp
17.66%
8,851,823
SC 13G/A
Feb 11, 2022
renaissance technologies llc
5.24%
2,612,396
SC 13G/A
Feb 10, 2022
state street corp
12.61%
6,280,258
SC 13G
Feb 04, 2022
wellington management group llp
8.35%
4,162,517
SC 13G/A
Jan 27, 2022
blackrock inc.
11.6%
5,760,841
SC 13G/A

NUS Fair Value

Recent SEC filings of NU Skin Enterprises

View All Filings
Date Filed Form Type Document
May 26, 2023
4
Insider Trading
May 25, 2023
144
Notice of Insider Sale Intent
May 24, 2023
SD
SD
May 15, 2023
144
Notice of Insider Sale Intent
May 09, 2023
144
Notice of Insider Sale Intent
May 09, 2023
4
Insider Trading
May 04, 2023
10-Q
Quarterly Report
May 03, 2023
8-K
Current Report
Apr 25, 2023
4
Insider Trading
Apr 25, 2023
4
Insider Trading

Latest Insider Trading transactions for NUS

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-05-09
WOODBURY EDWINA D
sold
-47,526
37.87
-1,255
-
2023-04-25
LIPMAN ANDREW D
sold
-81,500
40.75
-2,000
-
2023-04-21
Tang Connie Mang Yee
sold (taxes)
-46,334
41.37
-1,120
chief global growth officer
2023-03-31
Thomas James D
acquired
-
-
6,360
interim cfo
2023-03-27
LIPMAN ANDREW D
sold
-78,580
39.29
-2,000
-
2023-03-09
Hatchett Steven Keith
sold
-841,546
39.78
-21,155
chief product officer
2023-03-09
Hatchett Steven Keith
acquired
644,170
30.45
21,155
chief product officer
2023-03-08
WOODBURY EDWINA D
acquired
596
39.74
15.00
-
2023-03-02
CHANG JOSEPH Y
acquired
761,358
30.4543
25,000
chief scientific officer
2023-03-02
CHANG JOSEPH Y
sold
-1,019,250
40.77
-25,000
chief scientific officer

1–10 of 50

About NU Skin Enterprises

NUS Income Statement

2023-03-31
Consolidated Statements of Income (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Consolidated Statements of Income [Abstract]  
Revenue$ 481,462$ 604,899
Cost of sales133,588161,499
Gross profit347,874443,400
Operating expenses:  
Selling expenses188,124242,699
General and administrative expenses133,899148,556
Restructuring and impairment expenses9,7870
Total operating expenses331,810391,255
Operating income16,06452,145
Other income (expense), net(1,476)(1,453)
Income before provision for income taxes14,58850,692
Provision for income taxes3,21211,976
Net income$ 11,376$ 38,716
Net income per share (Note 6):  
Basic (in dollars per share)$ 0.23$ 0.77
Diluted (in dollars per share)$ 0.23$ 0.76
Weighted-average common shares outstanding:  
Basic (in shares)49,64449,991
Diluted (in shares)50,05851,066

NUS Balance Sheet

2023-03-31
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 229,941$ 264,725
Current investments16,77413,784
Accounts receivable, net60,00847,360
Inventories, net366,537346,183
Prepaid expenses and other100,30287,816
Total current assets773,562759,868
Property and equipment, net437,986444,806
Operating lease right-of-use assets98,68398,734
Goodwill206,432206,432
Other intangible assets, net64,71166,701
Other assets243,271244,429
Total assets1,824,6451,820,970
Current liabilities:  
Accounts payable49,49453,963
Accrued expenses275,774280,280
Current portion of long-term debt47,50025,000
Total current liabilities372,768359,243
Operating lease liabilities78,77676,540
Long-term debt372,609377,466
Other liabilities107,522110,425
Total liabilities931,675923,674
Commitments and contingencies (Notes 5 and 11)
Stockholders' equity:  
Class A common stock - 500 million shares authorized, $0.001 par value, 90.6 million shares issued9191
Additional paid-in capital611,483613,278
Treasury stock, at cost - 40.7 million and 41.1 million shares(1,559,080)(1,569,061)
Accumulated other comprehensive loss(91,005)(86,509)
Retained earnings1,931,4811,939,497
Total stockholders' equity892,970897,296
Total liabilities and stockholders' equity$ 1,824,645$ 1,820,970